Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Cns Pharmaceuticals Inc

Current price
0.2 USD -0.0001 USD (-0.05%)
Last closed 0.21 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 2 482 973 USD
Yield for 12 month -88.29 %
21.11.2021 - 28.11.2021

CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, which completed Phase I clinical trial that is used for the treatment of glioblastoma multiforme. CNS Pharmaceuticals, Inc. has license agreements with Houston Pharmaceuticals, Inc. and The University of Texas M.D. Anderson Cancer Center, as well as a collaboration and asset purchase agreement with Reata Pharmaceuticals, Inc. The company was incorporated in 2017 and is based in Houston, Texas. Address: 2100 West Loop South, Houston, TX, United States, 77027

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
MSFT MSFT Microsoft


WallStreet Target Price

10 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

+6 362 USD

Last Quarter

Current Year

-4 134 USD

Last Year

-11 756 USD

Current Quarter

+5 409 USD

Last Quarter

Key Figures CNSP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -17 479 778 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -240.8 %
PEG Ratio
Return On Equity TTM -1018.78 %
Wall Street Target Price 10 USD
Revenue TTM
Book Value -0.42 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -7.82 USD
Diluted Eps TTM -7.82 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics CNSP

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History CNSP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:30
Payout Ratio
Last Split Date 29.11.2022
Dividend Date

Stock Valuation CNSP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -0.1243
Price Book MRQ 4.571

Financials CNSP

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators CNSP

For 52 weeks

0.19 USD 2.98 USD
50 Day MA 0.25 USD
Shares Short Prior Month 31 224
200 Day MA 1.02 USD
Short Ratio 0.2
Shares Short 62 455
Short Percent 0.57 %

Dynamics of changes in the value of assets




430.16 USD Microsoft Corporation +3.16 (+0.74%)
Detailed analytics

ETF funds



14.70 EUR iShares EURO STOXX Banks 30-15 UCITS ETF (DE) +0.1 (+0.64%)
Detailed analytics



2357.98 USD Gold +6.23 (+0.27%)
Detailed analytics